Diligence memo · auto-generated · as of July 2, 2026
MTrap Inc.
MTrap Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
MTrap Inc. operates in Biotechnology, based in HUNTINGTON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
MTrap Inc. has raised $6.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $6.0M on 2016-06-28.
Most recent recorded round closed around 2016-06-28.
Valuation (modeled)modeled
Provath models MTrap Inc. at approximately $217M (range $6.5M–$1.2B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.03× the median modeled value of Series A Biotechnology companies in 2016–2018 (157 peers) — value vs value, same stage and era. Within the normal band (103% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 10.0 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 47% of Biotechnology peers (4291 compared).
Modeled value ranks above 73% of those peers.
Closest niche peers: Cynvec LLC, Anthera Pharmaceuticals Inc, Bio-Dent, LTD. LLC, Biothera Holding Corp., Limelight Bio, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.